Scherrer, Urs

Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase

Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., et al. (2001) · Circulation

Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 533

The thyroid and the heart.

Polikar, R., Burger, A. G., Scherrer, U., & Nicod, P. (1993) · Circulation

Thyroid Disorders and TreatmentsCardiac electrophysiology and arrhythmias

Cited by 475

Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart Transplantation

Scherrer, U., Vissing, S. F., Morgan, B. J., Rollins, J. A., Tindall, R. S. A., Ring, S., Hanson, P., Mohanty, P. K., & Victor, R. G. (1990) · New England Journal of Medicine

Blood Pressure and Hypertension StudiesTransplantation: Methods and Outcomes

Cited by 408

Secondary arterial hypertension: when, who, and how to screen?

Rimoldi, S. F., Scherrer, U., & Messerli, F. H. (2014) · European Heart Journal

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 393

Body fat and sympathetic nerve activity in healthy subjects.

Scherrer, U., Randin, D., Tappy, L., Vollenweider, P., Jéquier, E., & Nicod, P. (1994) · Circulation

Cardiovascular and exercise physiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 383

Insulin as a Vascular and Sympathoexcitatory Hormone: Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity

Scherrer, U., & Sartori, C. (1997) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension Studies

Cited by 371

Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans

Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993) · Journal of Clinical Investigation

Cardiovascular and exercise physiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 321

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.

Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular and exercise physiology

Cited by 285

Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans.

Scherrer, U., Vollenweider, P., Randin, D., Jéquier, E., Nicod, P., & Tappy, L. (1993) · Circulation

Cardiovascular and exercise physiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 131

Endothelial Nitric Oxide Synthase (eNOS) Knockout Mice Have Defective Mitochondrial β-Oxidation

Gouill, E. L., Jimenez, M., Binnert, C., Jayet, P.-Y., Thalmann, S., Nicod, P., Scherrer, U., & Vollenweider, P. (2007) · Diabetes

Mitochondrial Function and PathologyAdipose Tissue and Metabolism

Cited by 130

Fetal programming of pulmonary vascular dysfunction in mice: role of epigenetic mechanisms

Rexhaj, E., Bloch, J., Jayet, P.-Y., Rimoldi, S. F., Dessen, P., Mathieu, C., Tolsa, J.-F., Nicod, P., Scherrer, U., & Sartori, C. (2011) · American Journal of Physiology-Heart and Circulatory Physiology

Birth, Development, and HealthPulmonary Hypertension Research and Treatments

Cited by 109

Sympathetic-Nerve Activity before and after Resection of an Insulinoma

Scherrer, U., Owlya, R., & Trueb, L. (1996) · New England Journal of Medicine

Blood Pressure and Hypertension StudiesNeuroendocrine Tumor Research Advances

Cited by 22